Literature DB >> 16230445

Impact of pre-diabetic state on clinical outcomes in patients with acute coronary syndrome.

R Otten, E Kline-Rogers, D J Meier, R Dumasia, J Fang, N May, Y Resin, D F Armstrong, F Saab, M Petrina, K A Eagle, D Mukherjee.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16230445      PMCID: PMC1769179          DOI: 10.1136/hrt.2004.052845

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


× No keyword cloud information.
  5 in total

1.  Diagnosis and classification of diabetes mellitus.

Authors: 
Journal:  Diabetes Care       Date:  2004-01       Impact factor: 19.112

2.  Presentation, management, and outcomes of diabetic patients compared to non-diabetic patients admitted for acute coronary syndromes.

Authors:  T S Fergus; R Fazel; J Fang; S Chetcuti; D E Smith; E Kline-Rogers; K Munir; K A Eagle; D Mukherjee
Journal:  Heart       Date:  2004-09       Impact factor: 5.994

3.  Admission plasma glucose. Independent risk factor for long-term prognosis after myocardial infarction even in nondiabetic patients.

Authors:  A M Norhammar; L Rydén; K Malmberg
Journal:  Diabetes Care       Date:  1999-11       Impact factor: 19.112

4.  Fasting blood glucose: an underestimated risk factor for cardiovascular death. Results from a 22-year follow-up of healthy nondiabetic men.

Authors:  J V Bjørnholt; G Erikssen; E Aaser; L Sandvik; S Nitter-Hauge; J Jervell; J Erikssen; E Thaulow
Journal:  Diabetes Care       Date:  1999-01       Impact factor: 19.112

5.  Glucose metabolism in patients with acute myocardial infarction and no previous diagnosis of diabetes mellitus: a prospective study.

Authors:  Anna Norhammar; Ake Tenerz; Göran Nilsson; Anders Hamsten; Suad Efendíc; Lars Rydén; Klas Malmberg
Journal:  Lancet       Date:  2002-06-22       Impact factor: 79.321

  5 in total
  7 in total

1.  Conventional insulin vs insulin infusion therapy in acute coronary syndrome diabetic patients.

Authors:  Caterina Arvia; Valeria Siciliano; Kyriazoula Chatzianagnostou; Gillian Laws; Alfredo Quinones Galvan; Chiara Mammini; Sergio Berti; Sabrina Molinaro; Giorgio Iervasi
Journal:  World J Diabetes       Date:  2014-08-15

2.  Blood glucose control and coronary heart disease.

Authors:  Cristina Bianchi; Giuseppe Penno; Roberto Miccoli; Stefano Del Prato
Journal:  Herz       Date:  2010-05       Impact factor: 1.443

3.  Activin A levels are associated with abnormal glucose regulation in patients with myocardial infarction: potential counteracting effects of activin A on inflammation.

Authors:  Geir Ø Andersen; Thor Ueland; Eva C Knudsen; Hanne Scholz; Arne Yndestad; Afaf Sahraoui; Camilla Smith; Tove Lekva; Kari Otterdal; Bente Halvorsen; Ingebjørg Seljeflot; Pål Aukrust
Journal:  Diabetes       Date:  2011-04-04       Impact factor: 9.461

4.  Long term prognostic implication of newly detected abnormal glucose tolerance among patients with stable cardiovascular disease: a population-based cohort study.

Authors:  Maryam Kabootari; Samaneh Asgari; Seyedeh Maryam Ghavam; Hengameh Abdi; Fereidoun Azizi; Farzad Hadaegh
Journal:  J Transl Med       Date:  2021-06-30       Impact factor: 5.531

5.  The relationship between fasting plasma glucose and MPO in patients with acute coronary syndrome.

Authors:  Xiangyu Zhang; Lini Dong; Qiong Wang; Xiaomei Xie
Journal:  BMC Cardiovasc Disord       Date:  2015-08-25       Impact factor: 2.298

6.  Impaired Glucose Tolerance or Newly Diagnosed Diabetes Mellitus Diagnosed during Admission Adversely Affects Prognosis after Myocardial Infarction: An Observational Study.

Authors:  Anish George; Raghav T Bhatia; Gill L Buchanan; Anne Whiteside; Robert S Moisey; Stephen F Beer; Sudipta Chattopadhyay; Thozhukat Sathyapalan; Joseph John
Journal:  PLoS One       Date:  2015-11-16       Impact factor: 3.240

7.  Long-term prognosis in patients with acute myocardial infarction and newly detected glucose abnormalities: predictive value of oral glucose tolerance test and HbA1c.

Authors:  Stelios Karayiannides; Catarina Djupsjö; Jeanette Kuhl; Claes Hofman-Bang; Anna Norhammar; Martin J Holzmann; Pia Lundman
Journal:  Cardiovasc Diabetol       Date:  2021-06-14       Impact factor: 9.951

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.